Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Psioxus Therapeutics
1248
Psioxus Therapeutics
Health Care
Medical
Therapeutics
Immuno-oncology specialists with a clinical stage oncolytic virus program and the T-SIGn plaform for immuno-gene-therapy
Suggest edits
Founded
2010
Raised
$73.4M
Follow us
Featured on
Also headquartered in Oxford
Oxford University
Newton
Oxbotica
Oxford Nanopore
Latent Logic
Exscientia
Contego
Navenio
University of Oxford
PQShield
Companies in the same industry
Agilvax
AdoRx Therapeutics
Gotham Therapeutics
Stelexis Therapeutics
Imcyse
Bold Health
Eureka Therapeutics
Fountain Therapeutics
Forge Biologics
Siolta Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Add round
19 May
2015
$39,241,539
Venture capital (Series C)
09 Jul
2012
$34,118,753
Venture capital (Series B)
